Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Dec;1(6):526-32.
doi: 10.1016/j.coviro.2011.10.007.

Antiretroviral restriction factors

Affiliations
Review

Antiretroviral restriction factors

Theodora Hatziioannou et al. Curr Opin Virol. 2011 Dec.

Abstract

Studies of retroviruses have been instrumental in revealing the existence of an array of antiviral proteins, or restriction factors, and the mechanisms by which they function. Some restriction factors appear to specifically inhibit retrovirus replication, while others have a broader antiviral action. Here, we briefly review current understanding of the mechanisms by which several such proteins exert antiviral activity. We also discuss how retroviruses have evolved to evade or antagonize antiviral proteins, including through the action of viral accessory proteins. Restriction factors, their viral targets and antagonists have exerted evolutionary pressure on each other, resulting in specialization and barriers to cross-species transmission. Potentially, this recently revealed intrinsic system of antiviral immunity might be mobilized for therapeutic benefit.

PubMed Disclaimer

Figures

Figure
Figure. Factors and events in the restriction of retroviral replication by host proteins
Key retroviral restriction factors are shown in red, antagonists expressed by the HIV/SIV retroviruses are shown in green. Cellular cofactors, co-opted by viral antagonists are shown in purple. Key events or processes in the restriction of retroviral replication or associated with the action of the antagonists are indicated. The process of APOBEC3-mediated hypermutation is depicted in detail in the inset panel.

References

    1. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002;418:646–650. **Using complementary DNA substraction this paper first identified huAPOBEC3G (CEM15) as the protein that inhibits HIV-1 and is overcome by Vif. This is the first description of a cellular protein with specific activity against HIV-1 and marks the beginning of an explosion of interest in research on ‘restriction factors’.

    1. Conticello SG, Thomas CJ, Petersen-Mahrt SK, Neuberger MS. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol. 2005;22:367–377. - PubMed
    1. Sawyer SL, Emerman M, Malik HS. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2004;2:E275. - PMC - PubMed
    1. Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol. 2008;26:317–353. * In this compehensive review, Table 1 is especially useful as it summarizes the activity of various APOBEC3 viruses against exogenous and endogenous retroviruses and other viruses. See also reference #18.

    1. Schafer A, Bogerd HP, Cullen BR. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology. 2004;328:163–168. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources